Health-related Physical Fitness in Patients with Inflammatory Bowel Disease
NCT ID: NCT05482932
Last Updated: 2024-12-17
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
200 participants
OBSERVATIONAL
2022-08-17
2024-09-27
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Objective: The main objective of this study is to validate a simple screening tool and a best-practice assessment battery for the different components of HRPF against gold standard measures. Secondary objectives are to objectively assess the incidence of specific components affected in patients with IBD compared to healthy control subjects and to explore the association between these components of HRPF affected and patient-, disease-, and treatment-related factors.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Patients with IBD
100 patients with IBD; either Ulcerative Colitis (N=50) or Crohns disease (N=50)
Health-related physical fitness assessment
Participants will complete several questionnaires and perform multiple health-related physical fitness tests
Healthy volunteers without IBD
100 healthy volunteers (without IBD)
Health-related physical fitness assessment
Participants will complete several questionnaires and perform multiple health-related physical fitness tests
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Health-related physical fitness assessment
Participants will complete several questionnaires and perform multiple health-related physical fitness tests
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* American Society of Anesthesiologists (ASA) Physical Status I or II (i.e., normal healthy patient or a patient with mild systemic disease)
* No contraindications for exercise testing based on the PAR-Q
* Being able to provide written informed consent;
* Willing and able to complete questionnaires and perform performance tests;
* Being able to understand written Dutch and speak the Dutch language.
* Certified diagnosis of IBD (UC or CD) based on the combination of endoscopic, radiological, and/or histological findings;
* No active disease or experiencing mild to moderate disease activity.
* Included in eHealth clinical care-pathway using myIBDcoach.
• No certified diagnosis of IBD (CD, UC, IBD-Unclassified);
Exclusion Criteria
* Contraindications for exercise testing based on PAR-Q
* Other (temporary) injuries or severe (neuro)muscular, rheumatic, or orthopedic conditions that may interfere with study evaluations;
* Current malignancy (except for local cutaneous skin cancer) or successfully treated for a malignancy in the past 6 months;
* Pregnant or lactating women;
* Competitive and elite athletes (i.e., ≥6 hours/week of moderate to vigorous exercise)
* Not being able to understand or speak the Dutch language;
* Not being able to cooperate with test procedures or unable to provide informed consent.
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Dutch Gastroenterology & Hepatology Foundation (Maag Lever Darm Stichting)
UNKNOWN
Maastricht University Medical Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
M.J. Pierik, Prof.
Role: PRINCIPAL_INVESTIGATOR
Maastricht University Medical Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Maastricht University Medical Center +
Maastricht, Limburg, Netherlands
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ZP 21-13
Identifier Type: OTHER_GRANT
Identifier Source: secondary_id
NL79305.068.22
Identifier Type: -
Identifier Source: org_study_id